Dendritic cell (DC) differentiation was investigated in samples from two ac
ute promyelocytic leukaemia (APL) patients with classic translocation t(15;
17)(q22;q21). After 18 d of culture in the presence of granulocyte-macropha
ge colony-stimulating factor, interleukin 4 and tumour necrosis factor alph
a, 10-15% of pathological promyelocytes had differentiated into DC-like cel
ls, as demonstrated by immunological and functional characteristics and by
analysis of CD1a(+) cells. In one patient, analysed at relapse and after de
veloping a picture of secondary myelodysplastic syndrome (MDS), three diffe
rent populations of DCs were demonstrated, two of which derived from pathol
ogical myeloid precursors (the APL and the MDS clones). This patient's DCs
also presented abnormal dextran uptake. Our results demonstrated that patho
logical myeloid precursors in APL can differentiate into DC-like elements a
nd that different populations of pathological DCs may Coexist in the same p
atient.